Emmes is a pioneering full-service clinical research organization (CRO) committed to advancing human health through rigorous scientific methods and innovative technology. Established to support biopharmaceutical, governmental, non-profit, and academic partners, Emmes transforms clinical trial workflows to enhance efficiency and quality. The organization specializes in a range of therapeutic areas including Vaccines and Infectious Diseases, Ophthalmology, Clinical Neuroscience, Rare Diseases, and Cell and Gene Therapy. They utilize cutting-edge technology and AI to streamline patient and site engagement, data management, biostatistics, and bioinformatics.

Emmes offers comprehensive clinical services that encompass Biostatistics, Clinical Data Management, Clinical Trial Management, Global Regulatory Affairs, and Pharmacovigilance. Notably, they maintain an impressive client retention rate of 98%, having collaborated with 15 of the top 25 biopharma companies in recent years. With extensive experience and a track record of successful studies across over 30 million electronic case report forms, Emmes is dedicated to making a significant impact on the pharmaceutical research landscape and contributing to global health.